Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 16Thoracic 4Head & Neck 4Other solid neoplasm 3Gastrointestinal 3Breast 3Tumor-Agnostic 2Other neoplasm 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Melanoma 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Calcitriol × Dermatologic × Clear all
NCT00301067 2019-06-04

Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma

Northwestern University

Phase 1/2 Completed
20 enrolled 9 charts
Dermatologic

Melanoma

NCT01358045 2015-01-13

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

Maastricht University Medical Center

Phase 2 Completed
128 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡